4.1. AIDS General Treatment Information: References:
Description
This article is from the AIDS FAQ, by Dan Greening with numerous contributions by others.
4.1. AIDS General Treatment Information: References:
ZDV and The AIDS Clinical Trials Group (1989-93):
Aweeka FT. Gambertoglio JG. et al. Pharmacokinetics of concomitantly
administered foscarnet and zidovudine for treatment of human
immunodeficiency virus infection (AIDS Clinical Trials Group protocol
053). Antimicrobial Agents & Chemotherapy. 36(8):1773-8, 1992 Aug.
Fischl MA. Richman DD. et al. The safety and efficacy of zidovudine
(AZT) in the treatment of subjects with mildly symptomatic human
immunodeficiency virus type 1 (HIV) infection. A double-blind,
placebo-controlled trial. The AIDS Clinical Trials Group [see
comments]. Annals of Internal Medicine. 112(10):727-37, 1990 May
15. [Editor's Note: This article reports the results of ACTG 106.]
Fischl MA. Parker CB. et al. A randomized controlled trial of a
reduced daily dose of zidovudine in patients with the acquired
immunodeficiency syndrome. The AIDS Clinical Trials Group. New England
Journal of Medicine. 323(15): 1009-14, 1990 Oct 11.
Gelber RD. Lenderking WR. et al. Quality-of-life evaluation in a
clinical trial of zidovudine therapy in patients with mildly
symptomatic HIV infection. The AIDS Clinical Trials Group. Annals of
Internal Medicine. 116(12 Pt 1):961-6, 1992 Jun 15.
Hochster H. Dieterich D. et al. Toxicity of combined ganciclovir and
zidovudine for cytomegalovirus disease associated with AIDS. An AIDS
Clinical Trials Group Study. Annals of Internal
Medicine. 113(2):111-7, 1990 Jul 15.
Kahn JO. Lagakos SW. et al. A controlled trial comparing continued
zidovudine with didanosine in human immunodeficiency virus
infection. The NIAID AIDS Clinical Trials Group [see comments]. New
England Journal of Medicine. 327(9):581-7, 1992 Aug 27.
Koch MA. Volberding PA. et al. Toxic effects of zidovudine in
asymptomatic human immunodeficiency virus-infected individuals with
CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated
results from protocol 019 of the AIDS Clinical Trials Group. Archives
of Internal Medicine. 152(11):2286-92, 1992 Nov.
Krogstad DJ. Eveland MR. et al. Drug level monitoring in a
double-blind multicenter trial: false-positive zidovudine measurements
in AIDS clinical trials group protocol 019. Antimicrobial Agents &
Chemotherapy. 35(6): 1160-4, 1991 Jun.
Meng TC. Fischl MA. Richman DD. AIDS Clinical Trials Group: phase I/II
study of combination 2',3'-dideoxycytidine and zidovudine in patients
with acquired immunodeficiency syndrome (AIDS) and advanced
AIDS-related complex. American Journal of Medicine. 88(5B):27S-30S,
1990 May 21.
Sidtis JJ. Gatsonis C. et al. Zidovudine treatment of the AIDS
dementia complex: results of a placebo-controlled trial. AIDS Clinical
Trials Group. Annals of Neurology. 33(4):343-9, 1993 Apr.
Sperling RS. Stratton P. Treatment options for human immunodeficiency
virus-infected pregnant women. Obstetric- Gynecologic Working Group of
the AIDS Clinical Trials Group of the National Institute of Allergy
and Infectious Diseases. Obstetrics & Gynecology. 79(3):443-8, 1992
Mar.
Volberding PA. Lagakos SW. et al. Zidovudine in asymptomatic human
immunodeficiency virus infection. A controlled trial in persons with
fewer than 500 CD4-positive cells per cubic millimeter. The AIDS
Clinical Trials Group of the National Institute of Allergy and
Infectious Diseases [see comments]. New England Journal of
Medicine. 322(14):941-9, 1990 Apr 5. [Editor's Note: This article
reports the results of ACTG 109.]
See also:
Aboulker JP. Swart AM. Preliminary analysis of the Concorde
trial. Concorde Coordinating Committee [letter]. Lancet. 1993 Apr
3;341(8849):889-90. Comment in: Lancet 1993 Apr 17;341(8851): 1022-3;
Lancet 1993 Apr 17;341(8851):1023; Lancet 1993 May 15; 341(8855):1276;
Lancet 1993 May 15;341 (8855):1276-7; and Lancet 1993 May
15;341(8855):1277.
Cooper DA. Gatell M. et al. Zidovudine in persons with asymptomatic
HIV infection and CD4+ cell counts greater than 400 per cubic
millimeter. New England Journal of Medicine. 329(5): 297-303, 1993 Jul
29.
Hamilton JD. Hartigan PM. et al. A controlled trial of early versus
late treatment with zidovudine in symptomatic human immunodeficiency
virus infection. Results of the Veterans Affairs Cooperative
Study. New England Journal of Medicine. 326(7):437- 43, 1992 Feb 13.
Continue to:
My Books
